CD274 and hepatocellular carcinoma: We showed that a combination therapy using 5-AZA and an antibody against PD-L1 reduced the growth of both lymphocytes and HCC cell lines, with a greater extent observed for the lymphocytes (4 out of 5 co-culture pairs).